US-Leitlinien empfehlen den Einsatz auch bei Typ-2-Diabetes
Crossref DOI link: https://doi.org/10.1007/s15034-024-4927-9
Published Online: 2024-02-22
Published Print: 2024-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2024-02-01
Version of Record valid from 2024-02-01
Article History
First Online: 22 February 2024
Free to read: This content has been made available to all.